Chaperoning a cure: unexpected role of CD74 in cutaneous T-cell lymphoma

Affiliations

Editorial

Robert Gniadecki. Br J Dermatol. 2025.

. 2025 Apr 28;192(5):792.

doi: 10.1093/bjd/ljaf040.

No abstract available

Conflict of interest statement

Conflicts of interest: None to declare.

Preclinical in vitro and in vivo evidence for targeting CD74 as an effective treatment strategy for cutaneous T-cell lymphomas.
Costanza M, Giordano C, von Brünneck AC, Zhao J, Makky A, Vinh K, Montes-Mojarro IA, Reisinger F, Forchhammer S, Witalisz-Siepracka A, Edtmayer S, Stoiber D, Yin G, Horst D, Fischer A, Siebert R, Nicolay JP, Yin M, Janz M, Fend F, Becker JC, Schürch CM, Kenner L, Assaf C, Merkel O, Mathas S. Costanza M, et al. Br J Dermatol. 2025 Apr 28;192(5):883-895. doi: 10.1093/bjd/ljaf001. Br J Dermatol. 2025. PMID: 40036608